BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11756159)

  • 1. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation.
    Kirito K; Nakajima K; Watanabe T; Uchida M; Tanaka M; Ozawa K; Komatsu N
    Blood; 2002 Jan; 99(1):102-10. PubMed ID: 11756159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of both erythroid and megakaryocytic differentiation of a human leukemia cell line, UT-7.
    Miura Y; Kirito K; Komatsu N
    Acta Haematol; 1998; 99(3):180-4. PubMed ID: 9587401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distinct function of STAT proteins in erythropoietin signal transduction.
    Kirito K; Uchida M; Yamada M; Miura Y; Komatsu N
    J Biol Chem; 1997 Jun; 272(26):16507-13. PubMed ID: 9195960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes.
    Tian SS; Tapley P; Sincich C; Stein RB; Rosen J; Lamb P
    Blood; 1996 Dec; 88(12):4435-44. PubMed ID: 8977235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils.
    Avalos BR; Parker JM; Ware DA; Hunter MG; Sibert KA; Druker BJ
    Exp Hematol; 1997 Feb; 25(2):160-8. PubMed ID: 9015216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
    Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM
    Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor.
    Shimoda K; Feng J; Murakami H; Nagata S; Watling D; Rogers NC; Stark GR; Kerr IM; Ihle JN
    Blood; 1997 Jul; 90(2):597-604. PubMed ID: 9226159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.
    Haq R; Halupa A; Beattie BK; Mason JM; Zanke BW; Barber DL
    J Biol Chem; 2002 May; 277(19):17359-66. PubMed ID: 11875080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route.
    Barge RM; de Koning JP; Pouwels K; Dong F; Löwenberg B; Touw IP
    Blood; 1996 Mar; 87(6):2148-53. PubMed ID: 8630373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells.
    Wang L; Arcasoy MO; Watowich SS; Forget BG
    Exp Hematol; 2005 Mar; 33(3):308-17. PubMed ID: 15730854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
    Sakamoto H; Kitamura T; Yoshimura A
    J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
    Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of Stat1 and Stat3 in primary erythroleukemia cells.
    Kirito K; Nagashima T; Ozawa K; Komatsu N
    Int J Hematol; 2002 Jan; 75(1):51-4. PubMed ID: 11843291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
    Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
    Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.